Viewing Study NCT02354235

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:22 PM
Ignite Modification Date: 2026-02-20 @ 11:09 AM
Study NCT ID: NCT02354235
Status: COMPLETED
Last Update Posted: 2018-11-01
First Post: 2015-01-29
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Confirmatory Study of MT-2412 in Japanese Patients With Type 2 Diabetes (Add-on Study of Canagliflozin)
Sponsor: Tanabe Pharma Corporation
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Type 2 Diabetes Mellitus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None MT-2412 View
None MP-513 View
None TA-7284 View
None Teneligliptin View
None Canagliflozin View